Global private equity and venture capital news and research

Posts Tagged ‘SV Life Sciences’

9 December 2014

VC-backed CardioKinetix lands $50m in new round

heart-shape-1442152-m US medical device firm CardioKinetix has closed a $50m financing round which include backing from several venture capital firms.

14 October 2014

Bicycle Therapeutics VC backers return for £20m financing round

Bicycle Therapeutics A string of venture capital firms have renewed their commitment to UK-based biotech business Bicycle Therapeutics through a £20m financing round.

8 July 2014

SV Life Sciences hires ex-Edison Ventures general partner Balmuth

balmuth SV Life Sciences has hired experienced venture capital investor Michael Balmuth as a partner in its healthcare services team not long after adding three new venture partners to its biotechnology investment division.

3 June 2014

SV Life Sciences brings in trio of venture partners for biotech investment team

microscope7_sq Specialist venture capital firm SV Life Sciences has hired a trio of new venture partners for its biotechnology investment team.

16 April 2014

Biopharma developer PanOptica scores $45m Series B investment

Biopharmaceutical company PanOptica has raised up to $45m in a Series B financing, co-led by new participant Novo Ventures and existing investor Third Rock Ventures, alongside founding investor SV Life Sciences.

1 April 2014

Investors exit biopharma services company Aptiv in $144m sale

Investors including the Halifax Group, SV Life Sciences and Comvest Partners have exited their stake in biopharmaceutical and medical device development services company Aptiv Solutions to ICON for $143.5m.

25 February 2014

Novo Ventures leads $49m Series B for anti-acne business Thesan Pharmaceuticals

skin5_lrg Biotechnology business Thesan Pharmaceuticals, which aims to treat skin disorders including acne and dermatitis, has picked up $49m of Series B financing led by existing backer Novo Ventures.

8 July 2013

OncoEthix raises $19m in SV Life Sciences-led Series B

Venture capital firm SV Life Sciences has led a CHF18m ($19m) Series B round for Swiss oncology drug development company OncoEthix.

28 February 2013

Panorama Capital backs CardioKinetix’s $48m Series E round

news_heartmonitor.lrg Medical devices maker CardioKinetix has successfully raised $48m via a Series E funding round, which was backed by new investor Panorama Capital.

7 January 2013

VC firm SV Life Sciences upgrades management team

International life sciences venture capital firm SV Life Sciences has appointed Darren Black as managing partner and Tom Flynn as partner.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015